Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study

NCT02933229 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT02933229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02933229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study
Lead sponsor
Shandong University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 31, 2016
Completion date
October 31, 2031
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori, operative link on gastric intestinal assessment, the operative link on gastric intestinal metaplasia